Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive‐resistant differentiated thyroid cancer

Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive‐resistant differentiated thyroid cancer

Abstract This review focuses on patients with differentiated thyroid carcinoma (DTC) associated with multiple primary malignant neoplasm (MPMN) treated by multikinase inhibitors (MKIs) as systemic treatment for advanced disease. Despite the increasing frequency of MPMNs (many at an advanced stage) a...

Full description

Bibliographic Details
Main Author:	Marcel Sambo
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	Cancer Medicine
Subjects:	differentiated thyroid carcinoma multikinase inhibitors multiple primary malignant neoplasms synchronous/metachronous cancers
Online Access:	https://doi.org/10.1002/cam4.5107

Similar Items

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
by: Urbano Anido Herranz
Published: (2022-10-01)

Use of multikinase inhibitors/lenvatinib in patients with high cardiovascular risk/vasculopathy and radioiodine refractory‐differentiated thyroid cancer
by: Paula Jimenez‐Fonseca
Published: (2022-10-01)

Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine‐resistant differentiated thyroid cancer
by: Elena Navarro‐Gonzalez
Published: (2022-10-01)

Triple Metachronous Malignancies with Thyroid Involvement: A Brief Overview of Five Case Reports over 20 Years of Institutional Experience
by: Bădan Marius-Ioan, et al.
Published: (2020-03-01)

Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer
by: Neus Basté Rotllan
Published: (2022-10-01)

A metachronous malignancy: An interesting case report
by: S Muthulakshmi, et al.
Published: (2021-01-01)

Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer
by: Hyeok Jun Yun, et al.
Published: (2023-06-01)

Predictors of Response and Survival to Multikinase Inhibitors in Radioiodine Resistant Differentiated Thyroid Cancer
by: Tiziana Feola, et al.
Published: (2021-07-01)

Neoadjuvant Multikinase Inhibitor in Patients With Locally Advanced Unresectable Thyroid Carcinoma
by: Carla Fernanda Nava, et al.
Published: (2019-10-01)

The role of multikinase inhibitors target therapy in radioiodine-resistant differentiated thyroid cancer
by: P O Rumyantsev
Published: (2015-06-01)

Rare complications of multikinase inhibitor treatment
by: Fabián Pitoia, et al.

Combination of targeted multikinase inhibitor and radioiodine: a new strategy of treatment for advanced differentiated thyroid carcinoma
by: LIU Wei
Published: (2023-11-01)

CLINICAL-STATISTICAL STUDY OF MULTIPLE SYNCHRONOUS AND METACRONE TUMORS
by: Nicoleta Aurelia Sanda, et al.
Published: (2019-06-01)

Synchronous Malignancies: Pathological Analysis of Three Patients, Each with Dual Malignancies
by: Md Ali Osama, et al.
Published: (2023-12-01)

A RARE CASE: BILATERAL PHYLLODES TUMOR OF BREAST (METACHRONOUS AND SYNCHRONOUS)
by: Enver İlhan, et al.
Published: (2010-10-01)

Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor
by: Anna Strasma, et al.
Published: (2021-03-01)

Prognostic factors in patients with advanced differentiated thyroid cancer treated with multikinase inhibitors – a single Brazilian center experience
by: Natalia Treistman, et al.
Published: (2021-05-01)

Breast Cancer with Synchronous Renal Cell Carcinoma: A Rare Presentation
by: Ravi Arjunan, et al.
Published: (2016-10-01)

Two rare cases of synchronous and metachronous colonic metastases in patients with advanced gastric cancer
by: Wei-Chih Su, et al.
Published: (2018-01-01)

Synchronous/Metachronous Multiple Primary Malignancies: Review of Associated Risk Factors
by: Szu-Ying Pan, et al.
Published: (2022-08-01)

Novel analytical tools reveal that local synchronization of cilia coincides with tissue-scale metachronal waves in zebrafish multiciliated epithelia
by: Christa Ringers, et al.
Published: (2023-01-01)

Features of development of metachronous and synchronous tumors in the population of Belgorod region associated with the consequences of the Chernobyl accident
by: B S Kovalenko, et al.
Published: (2014-12-01)

Metachronous Malignant Fibrous Histiocytoma- A Rare Case Report
by: Gireesha Rawal, et al.
Published: (2018-10-01)

Nutrition in Advanced Thyroid Cancer Patients
by: Laura Agate, et al.
Published: (2022-03-01)

Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
by: Pariyada Tanjak, et al.
Published: (2021-09-01)

Double primary cancers registered in a tertiary care hospital: review of two cases
by: Mohammad Amrallah A., et al.
Published: (2014-08-01)

Metachronous malignancies in head and neck region: Report of two cases
by: Sushma Yalavarthi, et al.
Published: (2014-01-01)

Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer Center
by: Giulia Tasca, et al.
Published: (2020-12-01)

Multiple primary cancers: An enigma
by: Amitabh Jena, et al.
Published: (2016-01-01)

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases
by: Zheng P, et al.
Published: (2018-08-01)

Comparison of prognostic factors that affect the survival of patients with metachronous and synchronous metastases of renal cell carcinoma
by: D. V. Semenov, et al.
Published: (2022-10-01)

Some patterns of development radio-induced metachronous tumors
by: A. V. Vazhenin, et al.
Published: (2016-03-01)

Analysis of Clinical Characteristics of Lung Cancer Combined with  Multiple Primary Malignancies in Other Organs
by: Shuai ZHANG, et al.
Published: (2021-01-01)

Diagnosis and Treatment of Multiple Primary Lung Cancer
by: Jingjing HOU, et al.
Published: (2015-12-01)

The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells
by: Keli Lima, et al.
Published: (2023-07-01)

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis
by: Sung Han Kim, et al.
Published: (2019-07-01)

Multiple Primary Malignancies in Patients with Gynecologic Cancer
by: Eun-Jung Yang, et al.
Published: (2021-12-01)

The Distinction of Clinicopathological Characteristics, Treatment Strategy and Outcome in Colorectal Cancer Patients With Synchronous vs. Metachronous Bone Metastasis
by: Chen-xi Ma, et al.
Published: (2020-06-01)

Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic Analysis
by: Jenny Nyqvist, et al.
Published: (2017-11-01)

Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective
by: Stefano Guzzinati, et al.
Published: (2023-06-01)